Literature DB >> 351506

Hydrops amnii in sheep associated with hydranencephaly and arthrogryposis with wesselsbron disease and rift valley fever viruses as aetiological agents.

J A Coetzer, B J Barnard.   

Abstract

During the 1974/75 lambing season numerous reports were received from various parts of the Republic of South Africa and South West Africa of severe abdominal distension in ewes after vaccination with the attenuated Rift Valley fever and/or attenuated Wesselsbron disease vaccine. The ewes were vaccinated at different stages of gestation in spite of recommendations to the contrary, the syndrome being especially obvious in ewes immunized with one or both of these vaccines during the first trimester of pregnancy. In some of the flocks hydrops amnii was recorded in as many as 15% of the ewes. Many of the ewes so affected showed a prolonged gestation of up to 6-7 months and, towards the end of gestation, were unable to rise or walk. They eventually died of ketosis, hypostatic pneumonia and complications due to dystocia. The foetuses examined were malformed and larger than normal with a mass of 3,6-6,7 kg. They usually showed arthrogryposis, brachygnathy inferior, hydranencephaly, hypoplasia or segmental aplasia of the spinal cord and neurogenic muscular atrophy. The amnion contained 8,0-18,0 1 of amniotic fluid, the endometrium was oedematous, and cystic tube-like dilatations, 1-10 mm in diameter, filled with a clear fluid, were scattered in the endometrium. No definite conclusions as to the aetiology of the syndrome could be drawn from serological tests performed on the ewes, lambs or foetuses. Preliminary experimental work confirmed previous observations that the attenuated Wesselsbron disease vaccine virus is responsible for this syndrome and that the wild-type virus is also implicated. In addition, the attenuated Rift Valley fever vaccine virus was found to the responsible for arthrogryposis and hydranencephaly without hydrops amnii and for micrencephaly and arthrogryposis associated with hydrops amnii in the ewe.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 351506

Source DB:  PubMed          Journal:  Onderstepoort J Vet Res        ISSN: 0030-2465            Impact factor:   1.792


  27 in total

Review 1.  Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.

Authors:  Tetsuro Ikegami
Journal:  Expert Rev Vaccines       Date:  2017-05-02       Impact factor: 5.217

2.  Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope.

Authors:  Yan Wu; Yaohua Zhu; Feng Gao; Yongjun Jiao; Babayemi O Oladejo; Yan Chai; Yuhai Bi; Shan Lu; Mengqiu Dong; Chang Zhang; Guangmei Huang; Gary Wong; Na Li; Yanfang Zhang; Yan Li; Wen-Hai Feng; Yi Shi; Mifang Liang; Rongguang Zhang; Jianxun Qi; George F Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

3.  A study of the host range and distribution of antibody to Akabane virus (genus bunyavirus, family Bunyaviridae) in Kenya.

Authors:  F G Davies; D M Jessett
Journal:  J Hyg (Lond)       Date:  1985-08

4.  A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.

Authors:  Bonto Faburay; Maxim Lebedev; D Scott McVey; William Wilson; Igor Morozov; Alan Young; Juergen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2014-10       Impact factor: 2.133

5.  Porencephaly, hydranencephaly and leukoencephalopathy in ovine fetuses following transplacental infection with bovine virus diarrhoea virus: distribution of viral antigen and characterization of cellular response.

Authors:  M Hewicker-Trautwein; G Trautwein
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 6.  Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.

Authors:  Michele Bouloy; Ramon Flick
Journal:  Antiviral Res       Date:  2009-08-12       Impact factor: 5.970

7.  An investigation of flavivirus infections of cattle in Zimbabwe Rhodesia with particular reference to Wesselsbron virus.

Authors:  N K Blackburn; R Swanepoel
Journal:  J Hyg (Lond)       Date:  1980-08

8.  Over 100 Years of Rift Valley Fever: A Patchwork of Data on Pathogen Spread and Spillover.

Authors:  Gebbiena M Bron; Kathryn Strimbu; Hélène Cecilia; Anita Lerch; Sean M Moore; Quan Tran; T Alex Perkins; Quirine A Ten Bosch
Journal:  Pathogens       Date:  2021-06-05

Review 9.  The pathogenesis of Rift Valley fever.

Authors:  Tetsuro Ikegami; Shinji Makino
Journal:  Viruses       Date:  2011-05       Impact factor: 5.048

10.  Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus.

Authors:  Jacquelyn M Bales; Diana S Powell; Laura M Bethel; Douglas S Reed; Amy L Hartman
Journal:  Front Cell Infect Microbiol       Date:  2012-08-02       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.